United States Daily Briefing

Intel surged $4.30 to $120.23, the best performance among S&P large-caps on the session, as quarter-end short-covering collided with renewed optimism around its foundry pivot and potential partnership updates. At current levels INTC has nearly doubled off its 2025 lows, which means the easy money from the turnaround trade is gone — what matters now is whether Q3 earnings (due mid-October) show foundry revenue inflecting. A miss on gross margin guidance would wipe this move fast.

Mastercard lost $12.11 to $551.47 and UnitedHealth dropped $7.86 to $367.08 in lockstep with broader Financials (-1.13%) and Healthcare (-1.35%) sector weakness — a classic quarter-end rebalancing flush where institutional desks trim outperformers to lock gains. WMT (-2.70%) and PG (-2.05%) getting hit alongside MA and UNH confirms this wasn't thematic selling; it was mechanical. Watch whether these names catch a bid Thursday morning as rebalancing pressure clears — if they don't bounce, that's a sector rotation signal, not noise.

META fell 1.84% to $725.18 even as the Tech sector posted gains, a divergence that points to stock-specific pressure rather than macro selling. At a $725 handle META trades at roughly 25x forward earnings — not egregious, but leaving no room for any Q3 ad-revenue softness when it reports in late October. The CRM +1.89% and AMZN +1.01% gains suggest enterprise software and cloud held while consumer-facing ad platforms faced skepticism. If macro data Thursday disappoints, META's relative weakness today looks like a leading indicator.